Drug Shortage Report for ABILIFY

Last updated on 2021-10-13 History
Report ID 141232
Drug Identification Number 02322404
Brand name ABILIFY
Common or Proper name Abilify
Company Name OTSUKA PHARMACEUTICAL CO LTD
Market Status MARKETED
Active Ingredient(s) ARIPIPRAZOLE
Strength(s) 15MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size bottle format
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2021-08-16
Actual start date
Estimated end date
Actual end date 2021-10-12
Shortage status Resolved
Updated date 2021-10-13
Company comments Resolved
Health Canada comments
Tier 3 Status No
Contact Address 2-9 KANDA-TSUKASAMACHI
CHIYODA-KU TOKYO, --
JAPAN 101-8535
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-10-13 English Compare
v5 2021-10-12 French Compare
v4 2021-10-12 English Compare
v3 2021-08-17 English Compare
v2 2021-06-18 French Compare
v1 2021-06-18 English Compare

Showing 1 to 6 of 6